The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_000527.5(LDLR):c.1856T>G (p.Phe619Cys)

CA10585656

252085 (ClinVar)

Gene: LDLR
Condition: hypercholesterolemia, familial
Inheritance Mode: Semidominant inheritance
UUID: 828e15e9-c755-4c90-bf79-2e2d5b7bca86
Approved on: 2022-02-10
Published on: 2022-04-25

HGVS expressions

NM_000527.5:c.1856T>G
NM_000527.5(LDLR):c.1856T>G (p.Phe619Cys)
NC_000019.10:g.11120102T>G
CM000681.2:g.11120102T>G
NC_000019.9:g.11230778T>G
CM000681.1:g.11230778T>G
NC_000019.8:g.11091778T>G
NG_009060.1:g.35722T>G
ENST00000558518.6:c.1856T>G
ENST00000252444.9:n.2110T>G
ENST00000455727.6:c.1352T>G
ENST00000535915.5:c.1733T>G
ENST00000545707.5:c.1475T>G
ENST00000557933.5:c.1856T>G
ENST00000558013.5:c.1856T>G
ENST00000558518.5:c.1856T>G
ENST00000559340.1:n.437T>G
NM_000527.4:c.1856T>G
NM_001195798.1:c.1856T>G
NM_001195799.1:c.1733T>G
NM_001195800.1:c.1352T>G
NM_001195803.1:c.1475T>G
NM_001195798.2:c.1856T>G
NM_001195799.2:c.1733T>G
NM_001195800.2:c.1352T>G
NM_001195803.2:c.1475T>G

Likely Pathogenic

Met criteria codes 5
PM2 PS4_Supporting PP1 PP4 PP3
Not Met criteria codes 1
PM5

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Familial Hypercholesterolemia VCEP
The NM_000527.5 (LDLR): c.1856T>G (p.Phe619Cys) variant is classified as Likely Pathogenic for Familial Hypercholesterolemia by applying evidence codes (PM2, PP3, PP4, PS4_Supporting, PP1) as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (https://doi.org/10.1016/j.gim.2021.09.012). The supporting evidence is as follows: PM2 Met: This variant is absent in gnomAD (gnomAD v2.1.1). PP3 Met: REVEL = 0.856, which is above the threshold of 0.75. PP4 Met: This variant meets PM2 and is identified >1 index cases who met clinical criteria for FH after alternative causes for high cholesterol were excluded. PS4_Supporting Met: Variant meets PM2, and is identified in 2 unrelated index cases who fulfil DLCN criteria for FH diagnosis from different labs. One index case is from U4M - Lille University & CHRU Lille, Université de Lille - CHRU de Lille (SCV000583897.1), another index case is reported from Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands (PMID16250003, SCV000295717.2). PP1 Met: Variant segregates with FH phenotype in 2 informative meiosis in one family reported from U4M - Lille University & CHRU Lille, Université de Lille - CHRU de Lille (SCV000583897.1). There are two other variants in same codon: LDLR: NM_000527:c.1855T>C (p.Phe619Leu), LDLR: NM_000527:c.1856T>C (p.Phe619Ser), which are classified as Likely Pathogenic by these guidelines. Neither variant is classified as Pathogenic, therefore PM5 is not met.
Met criteria codes
PM2
This variant is absent in gnomAD (gnomAD v2.1.1).
PS4_Supporting
Variant meets PM2, and is identified in 2 unrelated index cases fulfil DLCN criteria for FH diagnosis from different labs. One index case is from U4M - Lille University & CHRU Lille, Université de Lille - CHRU de Lille (SCV000583897.1), another index case is reported from Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands (PMID16250003, SCV000295717.2).
PP1
Variant segregates with FH phenotype in 2 informative meiosis in one family reported from U4M - Lille University & CHRU Lille, Université de Lille - CHRU de Lille (SCV000583897.1).
PP4
This variant meets PM2 and is identified >1 index cases who met clinical criteria for FH after alternative causes for high cholesterol were excluded.
PP3
REVEL = 0.856, which is above the threshold of 0.75.
Not Met criteria codes
PM5
There are two other variants in same codon: LDLR: NM_000527:c.1855T>C (p.Phe619Leu), LDLR: NM_000527:c.1856T>C (p.Phe619Ser), which are classified as Likely Pathogenic by these guidelines. Neither variant is classified as Pathogenic, therefore PM5 is not met.
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.